toh

New murals created by youth with epilepsy will create a welcoming environment for people visiting The Ottawa Hospital’s Neuroscience Clinic

OTTAWA – Feb. 21, 2019 – Epilepsy Ottawa and Eisai Limited teamed up with The Ottawa Hospital and CHEO to help youth living with epilepsy transition into adult care through artwork. Two new murals will create a warm, welcoming environment for people visiting The Ottawa Hospital Neuroscience Clinic. Youth with epilepsy, and their families, created the murals together with the team of health-care professionals who will provide their care going forward.

In September 2018, Epilepsy Ottawa hosted an event called Painting in the Park, sponsored by Eisai Limited. Young people and their families were invited to Andrew Haydon Park to paint murals from the Foundation of Hospital Art. The event helped youth who are transitioning from CHEO’s pediatric epilepsy program to The Ottawa Hospital’s adult program by introducing them to their new patient care teams and their local community support agency in a positive, non-medical environment.

“Many young patients who transition from care at CHEO to The Ottawa Hospital often struggle with the difference in environment,” said Dr. Tadeu Fantaneanu, Director of the epilepsy program at The Ottawa Hospital. “Artwork like this will make these young patients feel a little more at home, and help them transition into the next chapter of their care.”

Epilepsy Ottawa and Eisai Limited donated the two murals, which will be housed in the Neuroscience Clinic waiting room at The Ottawa Hospital’s Civic Campus, helping those new to the hospital’s epilepsy program feel a little more comfortable in their new care environment.

“In creating this mural together, patients were introduced to the people who will be caring for them going forward,” said Nikki Porter, Executive Director, Epilepsy Ottawa. “We wanted this introduction to happen outside hospital walls, so that patients and their care providers could get to know each other in a social environment. This could help set the stage for the patient and care provider relationships going forward.”

The Ottawa Hospital

The Ottawa Hospital is one of Canada’s largest learning and research hospitals, with more than 1,200 beds, approximately 12,000 staff members and an annual budget of about $1.2 billion.

Our focus on learning and research helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.

The Ottawa Hospital has received the highest rating from Accreditation Canada, Accredited with Exemplary Standing, reflecting our commitment to provide the world-class, compassionate care we would want for our loved ones.

From the compassion of our people to the relentless pursuit of new discoveries, The Ottawa Hospital never stops seeking solutions to the most complex health-care challenges.

Epilepsy Ottawa

Epilepsy Ottawa is a not-for-profit, charitable agency dedicated to improving the quality of life for those living with epilepsy or seizure disorders and those closest to them through support services, education, advocacy, and on-going public awareness. Epilepsy Ottawa provides services to those affected by epilepsy in the Ottawa region, including the wider rural communities (Lanark County, Renfrew County, Prescott-Russell County, and Stormont Dundas & Glengarry Counties).

About CHEO

Dedicated to the best life for every child and youth, CHEO is a global leader in pediatric health care and research. Based in Ottawa, CHEO includes a hospital, children’s treatment centre, school and research institute, with satellite services located throughout Eastern Ontario. CHEO provides excellence in complex pediatric care, research and education. We are committed to partnering with families and the community to provide exceptional care — where, when and how it’s needed. CHEO is a founding member of Kids Health Alliance, a network of partners working to create a high quality, standardized and coordinated approach to pediatric health care that is centred around children, youth and their families. Every year, CHEO helps more than 500,000 children and youth from Eastern Ontario, western Quebec, Nunavut and Northern Ontario.

Eisai Limited

Eisai Limited (pronounced ā-zī) is the Canadian pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd, manufacturers of FYCOMPA and BANZEL. Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.

At Eisai Limited, human health care is our goal. We give first thought to patients and their families, and helping to increase the benefits health care provides. We have a passionate commitment to patient care that is the driving force behind our efforts in epilepsy.

Eisai Limited focuses on epilepsy, dementia related diseases and neurodegenerative diseases. Our Canadian products include FYCOMPA and BANZEL.